PLI scheme boosts production of over 35 products in India: Mandaviya
While addressing 'Indian Pharma -- Global Health Care' event to commemorate the diamond jubilee of IDMA in Mumbai, the minister underlined how government initiatives such as PLI scheme have been benefitting the health sector
Through Production Linked Incentive (PLI) scheme, the union government has tried to reduce import by encouraging domestic manufacturing of pharmaceuticals. PLI scheme has led to initiate production of more than 35 products in India, said Mansukh Mandaviya, Union Health Minister, recently. Mandaviya said the pharma industry has a vital role to play in realising the vision of Aatmanirbhar Bharat.
While addressing ‘Indian Pharma — Global Health Care’ event to commemorate the diamond jubilee of the Indian Drug Manufacturers’ Association (IDMA) in Mumbai, the minister underlined how government initiatives such as PLI scheme have been benefitting the health sector. Mandaviya said the government has been acting proactively in order to extend necessary support to the sector.
“Government is helping the industry by amending Drugs and Cosmetics Act, 1940, and promoting ease of doing business. We are involving the industry in decision-making processes. Also, through a series of webinars, the government has tried to reach out and consult industry and other stakeholders on the implementation of union budget provisions,” the minister added in his address.